Supporting the Development of Nanomedicine with Ultrafiltration
With around 46,000 publications in 2021 and over two thirds of all papers on the topic published in the last five years, nanoparticles are a top focus in R&D labs across the globe. It is easy to understand why, given the broad variety of materials and form factors lending themselves to a diverse range of applications.
One area of intense interest is the use of nanoparticles for the packaging and delivery of prophylactic and therapeutic agents. However, despite the intensity of research and even the availability of several approved drug formulations, nanomedicine is not without its challenges and remains in its infancy.
“Understanding how nanoparticles should be used to deliver the vaccines and therapeutics of the future is critical”
John Cashamn
PhD Global Product Manager, Lab Ultrafiltration
Sartorius